Paul Brooke

Managing Member of PMSV Holdings, a biotech, ESG and real estate investment firm. Executive Chairman of Caelum Bio, a pharmaceutical company focused on AL Amyloidosis. Board Member of Manning and Napier Mutual Funds, Cerus Endovascular and Pure Earth. Previously: Board of WebMD, Incyte, Viropharma and other public and private companies. Co-Founder and Managing Partner of venBio, a life sciences investment firm. Partner at Morgan Stanley, where he was Global Head of Health Care Research and Strategy. Managing Director at Tiger Management where he was responsible for health care investing, and Venture Partner at MPM Capital, a healthcare VC investor. As Chairman and CEO of Ithaka Acquisition Corp in 2008, he structured purchase of Alsius Corp and successfully sold its assets to Zoll Medical.